S23-412 One-Time Delivery of Genetically Engineered Stem Cells Enable Long-Term Secretion of Therapeutic Antibodies for Treatment of HIV-1 Stanford researchers have engineered hematopoietic stem cells to provide long-term secretion of chosen therapeutic antibodies, eliminating the need of repeated dosing for delivery. Matthew Porteus William Feist Sofia Luna